The ethical case for providing cost-free access to lifesaving HIV medications in Canada
| Autor: | Nicole R. Greenspan, Zack Marshall, Shelley Marshall, Chris Kaposy, Cynthia Kitson, Jill Allison |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Canada
medicine.medical_specialty National Health Programs Anti-HIV Agents 030231 tropical medicine Human immunodeficiency virus (HIV) Alternative medicine Private prescription HIV Infections medicine.disease_cause Health Services Accessibility 03 medical and health sciences 0302 clinical medicine Deductibles and Coinsurance medicine Humans 030212 general & internal medicine Qualitative Research Ethical issues business.industry Health Policy Free access Antiretroviral therapy Family medicine Costs and Cost Analysis business Qualitative research |
| Zdroj: | Healthcare Management Forum. 29:255-259 |
| ISSN: | 2352-3883 0840-4704 |
| Popis: | Antiretroviral therapy for HIV can be expensive if paid for out of pocket. In Canada, there are a variety of federal, provincial, and private prescription drug plans that lower the cost of these lifesaving medications for people living with HIV, and in some cases, these plans result in cost-free access. However, many people living with HIV must contend with high deductibles for their antiretroviral therapies, and many experience difficulty managing the administrative requirements of their drug plans. This article comments on some of the results of a qualitative study into ethical issues in HIV care. Access to antiretrovirals was a theme that emerged in this study. We argue on ethical grounds that provincial drug plans should guarantee cost-free access to antiretroviral therapies for people living with HIV with minimal administrative requirements. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|